Navigation Links
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Date:10/1/2013

ration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to Amgen's business.  Unless otherwise noted, Amgen is providing this information as of Oct. 1, 2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects.  Risks and uncertainties include whether the proposed transaction described in this press release can be completed in a timely manner, and whether the anticipated benefits of the proposed transaction can be achieved.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for Amgen to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and Amgen
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
2. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
3. Amgen To Participate At Citis 8th Annual Biotech Conference
4. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
5. Amgen to Highlight New Data at Upcoming ESC Congress 2013
6. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
7. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
8. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
9. Amgens Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
10. Amgen Announces Webcast of 2013 Second Quarter Financial Results
11. Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... , Sept. 30, 2014 One week after ... major milestone: Alzheimer,s Team reaches over 200,000 ... and caregivers, was developed to draw attention to clinical ... disease. It also provides inspirational support and fosters online ... as the leading healthcare concern for people over the ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... SPRING, Md., June 24, 2011 Breast cancer patients and ... 7:00 am outside of the Federal Drug Administration (FDA).  At ... anti-cancer drug Avastin from the approved medication list for treatment ... in 2008 for use to treat breast cancer. ...
...   - Dossier Re-Examination ... a leader in,the field of human gene therapy, ... its Marketing Authorisation Application,(MAA) for Glybera® (alipogene tiparvovec) ... Following a recent,meeting with the European Medicines Agency,s ...
Cached Medicine Technology:Breast Cancer Patients and Families Stand Up To FDA 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 3Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 4
(Date:9/30/2014)... 30, 2014 ADOAMNI, Inc. ... campaign through GoFundMe. The campaign, which surpassed its goal ... portion of the funds necessary to convert a diesel ... Stockton Unified School District (SUSD). The campaign rallied citizens ... portion of the funds necessary for the conversion of ...
(Date:9/30/2014)... 2014 The American Parkinson ... funding supporting seven Research grants to junior investigators ... to support post-doctoral scientists whose research training holds ... etiology and treatment of Parkinson’s disease, and eight ... and medical centers across the country intended to ...
(Date:9/30/2014)... With accolades like the Most Inspirational Lash Artist ... Brand of My Brand Lashes is a leader of lash ... the ability to teach. She leads with a passion for ... reputation. , With a background in Cosmetology that spans 11 ... and as an Instructor. She has operated two of her ...
(Date:9/30/2014)... Got grapes? UCLA researchers have demonstrated how resveratrol, an ... to inhibit growth of the bacteria that causes acne. ... a common acne medication, benzoyl peroxide, may enhance the ... into new treatments. , Published in the current online ... the early lab findings demonstrated that resveratrol and benzoyl ...
(Date:9/30/2014)... -- MIT engineers have devised a way to rapidly ... making it easier to discover promising new ways to ... antibodies, peptides, RNA, and DNA, to human patients. , ... Biology , the researchers used this technology to identify ... also to rodents. This type of high-speed screen could ...
Breaking Medicine News(10 mins):Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 2Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 4Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 2Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 3Health News:Antioxidant found in grapes uncorks new targets for acne treatment 2Health News:Antioxidant found in grapes uncorks new targets for acne treatment 3Health News:High-speed drug screen 2Health News:High-speed drug screen 3
... (NP) is pleased to share today the release of Mr. Umar ... the Mindanao region of the Philippines who was kidnapped from the ... 13. Jaleel is alive and is currently en route to ... the vicinity of Tipo Tipo on Basilan. Jaleel was released ...
... , ... final program for Biopolymers Symposium 2009 taking place September 28 - 30th in Chicago, ... ... -- IntertechPira is pleased to announce the Biopolymers Symposium 2009 conference and exhibit, taking ...
... A. Magana awarded $25,000 each for leadership in increasing diversity ... 3 Guillermo J. Camacho, a dentist in West Covina, ... at California State Polytechnic University, Pomona, that encourages students of ... founded and directs a program at Cabrillo College ...
... if you,re a woman trying to figure out how to please her ... the gift you really want for yourself. , , (Photo: ... that probably rules out the ,65 Mustang and the even-bigger screen TV. ... for millions of women - one that would actually be a true ...
... for early confirmation of bile duct, pancreatic cancers, , WEDNESDAY, ... have developed new tests that make it easier to diagnose ... study, the new tests more than doubled the detection rate ... are not discovered until their later stages. , "The earlier ...
... , Health insurer chooses Cincom Eloquence to streamline policy ... software provider Cincom Systems announces that Medica ( ... to more than 1.5 million members, has chosen Cincom ... document automation processes. , , Key considerations for ...
Cached Medicine News:Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 2Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 3Health News:Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 3Health News:Perfect Father's Day Gift: The Sound of Silence 2Health News:Perfect Father's Day Gift: The Sound of Silence 3Health News:New Tests Spot Tough-to-Detect Cancers Sooner 2Health News:Medica Selects Cincom's Document Automation Software 2Health News:Medica Selects Cincom's Document Automation Software 3
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: